BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27803053)

  • 21. Lack of Association between NOD2 rs3135500 and IL12B rs1368439 microRNA Binding Site SNPs and Colorectal Cancer Susceptibility in an Iranian Population.
    Chaleshi V; Tajali R; Savabkar S; Zali N; Mojarad EN; Haghazali M; Pasha S; Aghdaei HA; Zali MR; Vahedi M
    Microrna; 2016; 5(2):152-156. PubMed ID: 27426943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
    Sun K; Gong A; Liang P
    Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
    Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
    Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population.
    Yue AM; Xie ZB; Zhao HF; Guo SP; Shen YH; Wang HP
    Asian Pac J Cancer Prev; 2013; 14(5):3085-91. PubMed ID: 23803084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in mismatch repair genes and colorectal cancer risk and clinical outcome.
    Vymetalkova V; Pardini B; Rosa F; Di Gaetano C; Novotny J; Levy M; Buchler T; Slyskova J; Vodickova L; Naccarati A; Vodicka P
    Mutagenesis; 2014 Jul; 29(4):259-65. PubMed ID: 24755277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variants in microRNA target sites of 37 selected cancer-related genes and the risk of cervical cancer.
    Mi Y; Wang L; Zong L; Pei M; Lu Q; Huang P
    PLoS One; 2014; 9(1):e86061. PubMed ID: 24465869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis.
    Wu H; Kang H; Liu Y; Xiao Q; Zhang Y; Sun M; Liu D; Wang Z; Zhao H; Yao W; Jia T; Wang E; Zheng Z; Wei M
    Pharmacogenomics; 2013 Jun; 14(8):897-911. PubMed ID: 23746184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population.
    Azimzadeh P; Romani S; Mohebbi SR; Mahmoudi T; Vahedi M; Fatemi SR; Zali N; Zali MR
    Cancer Genet; 2012 Oct; 205(10):501-7. PubMed ID: 22939228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
    Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
    Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
    Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
    Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
    Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
    Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
    Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
    Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of
    Alhadheq AM; Purusottapatnam Shaik J; Alamri A; Aljebreen AM; Alharbi O; Almadi MA; Alhadeq F; Azzam NA; Semlali A; Alanazi M; Bazzi MD; Reddy Parine N
    Dis Markers; 2016; 2016():8289293. PubMed ID: 27746584
    [No Abstract]   [Full Text] [Related]  

  • 34. 3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.
    Cho SH; Ko JJ; Kim JO; Jeon YJ; Yoo JK; Oh J; Oh D; Kim JW; Kim NK
    PLoS One; 2015; 10(7):e0131125. PubMed ID: 26147304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals.
    Ying HQ; Peng HX; He BS; Pan YQ; Wang F; Sun HL; Liu X; Chen J; Lin K; Wang SK
    Oncotarget; 2016 Nov; 7(46):75865-75873. PubMed ID: 27713147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.
    Lin M; Gu J; Eng C; Ellis LM; Hildebrandt MA; Lin J; Huang M; Calin GA; Wang D; Dubois RN; Hawk ET; Wu X
    Clin Cancer Res; 2012 Jul; 18(14):3982-91. PubMed ID: 22661538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.
    Wang C; Sturgis EM; Chen X; Wei Q; Li G
    Oncotarget; 2016 Jun; 7(23):34472-9. PubMed ID: 27121322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk.
    Naccarati A; Pardini B; Stefano L; Landi D; Slyskova J; Novotny J; Levy M; Polakova V; Lipska L; Vodicka P
    Carcinogenesis; 2012 Jul; 33(7):1346-51. PubMed ID: 22581836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue Factor Pathway Inhibitor Gene Polymorphism -33T → C Predicts Improved Disease-Free Survival in Colorectal Cancer.
    Bazzarelli AK; Scheer AS; Tai LH; Seth R; de Souza CT; Petrcich W; Jonker DJ; Maroun JA; Carrier M; Auer RC
    Ann Surg Oncol; 2016 Jul; 23(7):2274-80. PubMed ID: 26968713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.